Cargando…
A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals
The process of developing and marketing new pharmaceuticals in the United States is driven by a need to maximize returns to shareholders. This results all too often in the production of new medications that are expensive and of marginal value to patients and society. In line with our heightened awar...
Autores principales: | Sorum, Paul, Stein, Christopher, Wales, Danielle, Pratt, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203670/ https://www.ncbi.nlm.nih.gov/pubmed/35546103 http://dx.doi.org/10.1177/00207314221100647 |
Ejemplares similares
-
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022) -
After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada
por: Lexchin, Joel
Publicado: (2022) -
Canada and the pharmaceutical industry in the time of COVID-19
por: Lexchin, Joel
Publicado: (2023) -
Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada
por: Lexchin, Joel
Publicado: (2023) -
Pharmaceutical study of Lauha Bhasma
por: Singh, Neetu, et al.
Publicado: (2010)